To Order: patrick@cotinis.com
CD152 |
|||
MO152A(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152A(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152B(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152B(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152CFB(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152CFB(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152F(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152F(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152F(V500) | ImmunoStep | 500 ug | EUR 60 |
CD152 |
|||
MO152PE(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152PE(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152PP(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152PP(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152PP5.5(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152PP5.5(V25) | ImmunoStep | 25 ug | EUR 60 |
CD152 |
|||
MO152PU(V100) | ImmunoStep | 100 ug | EUR 60 |
CD152 |
|||
MO152PU(V500) | ImmunoStep | 500 ug | EUR 60 |
CD152 antibody (PE) |
|||
61R-1314 | Fitzgerald | 100 ug | EUR 424.8 |
Description: Mouse monoclonal CD152 antibody (PE) |
CD152 antibody (biotin) |
|||
61R-CD152aMSBT | Fitzgerald | 500 ug | EUR 535.2 |
Description: Hamster monoclonal CD152 antibody (biotin) |
CD152 antibody (FITC) |
|||
61R-CD152aMSFT | Fitzgerald | 500 ug | EUR 548.4 |
Description: Hamster monoclonal CD152 antibody (FITC) |
CD152 antibody (PE) |
|||
61R-CD152aMSPE | Fitzgerald | 100 ug | EUR 360 |
Description: Hamster monoclonal CD152 antibody (PE) |
CD152 Antibody (FITC) |
|||
abx133968-100Assays | Abbexa | 100 Assays | EUR 526.8 |
CD152 Antibody (FITC) |
|||
abx133968-50Assays | Abbexa | 50 Assays | EUR 410.4 |
CD152 Antibody (Biotin) |
|||
20-abx200697 | Abbexa |
|
|
CD152 Antibody (FITC) |
|||
20-abx200699 | Abbexa |
|
|
Anti-CD152 Antibody |
|||
A00020 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal Antibody for CD152 Antibody (CTLA4) detection.tested for IHC in Human. |
Anti-CD152 antibody |
|||
STJ98747 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to CD152. |
Anti-CD152 antibody |
|||
STJ16100529 | St John's Laboratory | 200 µg | EUR 1023.6 |
Anti-CD152 Antibody |
|||
A1388-100 | Biovision | each | EUR 444 |
CD152 antibody (Azide Free) |
|||
10R-CD152aMSP | Fitzgerald | 500 ug | EUR 548.4 |
Description: Hamster monoclonal CD152 antibody (Azide Free) |
CD152 antibody (Azide Free) |
|||
10R-CD152bMSP | Fitzgerald | 500 ug | EUR 548.4 |
Description: Hamster monoclonal CD152 antibody (Azide Free) |
CD152 (CTLA-4) Antibody |
|||
abx021366-02mg | Abbexa | 0.2 mg | EUR 1220.4 |
CTLA-4 Antibody / CD152 |
|||
R32809 | NSJ Bioreagents | 100 ug | EUR 419 |
CTLA-4 Antibody / CD152 |
|||
RQ6465 | NSJ Bioreagents | 100ug | EUR 419 |
Description: CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4), also known as CD152, is a protein receptor that down regulates the immune system. It is a member of the immunoglobulin superfamily, which is expressed on the surface of Helper T cells and transmits an inhibitory signal to T cells. CTLA4 is similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B7-1 and B7-2 respectively, on antigen-presenting cells. CTLA4 transmits an inhibitory signal to T cells, whereas CD28 transmits a stimulatory signal. Blockade of CTLA4 expression in vitro augmented HIV-specific CD4-positive T-cell function. |
CTLA-4 Antibody / CD152 |
|||
V7700-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This CTLA4 antibody is specific to the soluble form of the protein. CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule. |
CTLA-4 Antibody / CD152 |
|||
V7700-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This CTLA4 antibody is specific to the soluble form of the protein. CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule. |
CTLA-4 Antibody / CD152 |
|||
V7700SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This CTLA4 antibody is specific to the soluble form of the protein. CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule. |
CTLA-4 Antibody / CD152 |
|||
RQ5483 | NSJ Bioreagents | 100 ul | EUR 419 |
Anti-CTLA4 (CD152) Monoclonal Antibody |
|||
M00020 | BosterBio | 100ug | EUR 476.4 |
Description: Rabbit Monoclonal CTLA4 (CD152) Antibody. Validated in IF, ICC, WB and tested in Human, Mouse, Rat. |
Anti-CTLA4 (CD152) Neutralizing Antibody |
|||
71212 | BPS Bioscience | 100 µg | EUR 490 |
Description: Neutralizing recombinant human monoclonal antibody recognizing the extracellular domain of CTLA4 and blocking binding of CTLA4 to B7.1 and B7.2. This antibody recognizes human CTLA4 but does not bind to murine CTLA4. This antibody has not been tested for cross-reactivity with other species. |
Hamster Anti CTLA-4 (CD152) Antibody |
|||
20-abx137133 | Abbexa |
|
|
Hamster Anti Mouse Cd152 Monoclonal Antibody |
|||
CABT-47114HM | Creative Diagnostics | 0.1 mg | EUR 546 |
Purified Anti-human CD152 Antibody *BN13* |
|||
11520000 | AAT Bioquest | 100 ug | EUR 164 |
APC Anti-human CD152 Antibody *BN13* |
|||
115201C0 | AAT Bioquest | 25 tests | EUR 179 |
APC Anti-human CD152 Antibody *BN13* |
|||
115201C1 | AAT Bioquest | 100 tests | EUR 505 |
APC Anti-human CD152 Antibody *BN13* |
|||
115201C2 | AAT Bioquest | 500 tests | EUR 1887 |
FITC Anti-human CD152 Antibody *BN13* |
|||
115201H0 | AAT Bioquest | 100 tests | EUR 245 |
FITC Anti-human CD152 Antibody *BN13* |
|||
115201H1 | AAT Bioquest | 500 tests | EUR 918 |
TRITC Anti-human CD152 Antibody *BN13* |
|||
115201I0 | AAT Bioquest | 100 tests | EUR 245 |
TRITC Anti-human CD152 Antibody *BN13* |
|||
115201I1 | AAT Bioquest | 500 tests | EUR 918 |
PacBlue Anti-human CD152 Antibody *BN13* |
|||
115201J0 | AAT Bioquest | 100 tests | EUR 245 |
PacBlue Anti-human CD152 Antibody *BN13* |
|||
115201J1 | AAT Bioquest | 500 tests | EUR 918 |
PacOrange Anti-human CD152 Antibody *BN13* |
|||
115201K0 | AAT Bioquest | 100 tests | EUR 245 |
PacOrange Anti-human CD152 Antibody *BN13* |
|||
115201K1 | AAT Bioquest | 500 tests | EUR 918 |
PE Anti-human CD152 Antibody *BN13* |
|||
115201L0 | AAT Bioquest | 25 tests | EUR 179 |
PE Anti-human CD152 Antibody *BN13* |
|||
115201L1 | AAT Bioquest | 100 tests | EUR 505 |
PE Anti-human CD152 Antibody *BN13* |
|||
115201L2 | AAT Bioquest | 500 tests | EUR 1887 |
PerCP Anti-human CD152 Antibody *BN13* |
|||
115201T0 | AAT Bioquest | 25 tests | EUR 179 |
PerCP Anti-human CD152 Antibody *BN13* |
|||
115201T1 | AAT Bioquest | 100 tests | EUR 505 |
PerCP Anti-human CD152 Antibody *BN13* |
|||
115201T2 | AAT Bioquest | 500 tests | EUR 1887 |
Anti-Hu CD152 Purified |
|||
11-785-C025 | ExBio | 0.025 mg | EUR 118.8 |
Anti-Hu CD152 Purified |
|||
11-785-C100 | ExBio | 0.1 mg | EUR 189.6 |
Anti-Hu CD152 APC |
|||
1A-785-T100 | ExBio | 100 tests | EUR 288 |
Anti-Hu CD152 PE |
|||
1P-785-T025 | ExBio | 25 tests | EUR 168 |
Anti-Hu CD152 PE |
|||
1P-785-T100 | ExBio | 100 tests | EUR 288 |
CTLA4 (CD152), Fc fusion |
|||
71149-1 | BPS Bioscience | 100 µg | EUR 150 |
Description: Human secreted CTLA4 , Fc fusion protein, also known as Cytotoxic T-lymphocyte-associated protein 4 and CD152. GenBank Accession No. NM_005214, a.a. 36-162 expressed in a HEK293 cell expression system. MW = 40.3 kDa (monomer). This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx139385-01mg | Abbexa | 0.1 mg | EUR 427.2 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx139386-01mg | Abbexa | 0.1 mg | EUR 427.2 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
20-abx133970 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
20-abx200703 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
20-abx225129 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx413284-02mg | Abbexa | 0.2 mg | EUR 811.2 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx413702-025mg | Abbexa | 0.25 mg | EUR 678 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx414772-025mg | Abbexa | 0.25 mg | EUR 678 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx414773-05mg | Abbexa | 0.5 mg | EUR 994.8 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx414774-01mg | Abbexa | 0.1 mg | EUR 526.8 |
Mouse Anti Human Cd152 Monoclonal Antibody,RPE |
|||
CABT-47107MH | Creative Diagnostics | 100 TEST | EUR 1008 |
APC/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201D0 | AAT Bioquest | 25 tests | EUR 210 |
APC/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201D1 | AAT Bioquest | 100 tests | EUR 587 |
APC/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201D2 | AAT Bioquest | 500 tests | EUR 1989 |
PE/Cy5 Anti-human CD152 Antibody *BN13* |
|||
115201M0 | AAT Bioquest | 25 tests | EUR 210 |
PE/Cy5 Anti-human CD152 Antibody *BN13* |
|||
115201M1 | AAT Bioquest | 100 tests | EUR 587 |
PE/Cy5 Anti-human CD152 Antibody *BN13* |
|||
115201M2 | AAT Bioquest | 500 tests | EUR 1989 |
PE/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201N0 | AAT Bioquest | 25 tests | EUR 210 |
PE/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201N1 | AAT Bioquest | 100 tests | EUR 587 |
PE/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201N2 | AAT Bioquest | 500 tests | EUR 1989 |
PerCP/Cy5.5 Anti-human CD152 Antibody *BN13* |
|||
115201U0 | AAT Bioquest | 25 tests | EUR 210 |
PerCP/Cy5.5 Anti-human CD152 Antibody *BN13* |
|||
115201U1 | AAT Bioquest | 100 tests | EUR 587 |
PerCP/Cy5.5 Anti-human CD152 Antibody *BN13* |
|||
115201U2 | AAT Bioquest | 500 tests | EUR 1989 |
CD152 [CTLA-4] Recombinant Protein |
|||
90-411 | ProSci | 100 ug | EUR 342.6 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
|||
90-412 | ProSci | 500 ug | EUR 556.8 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
|||
90-415 | ProSci | 100 ug | EUR 437.1 |
Description: CD152 [CTLA-4] and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4 + and CD8 + T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4 + T cells and 50% of CD8 + T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
|||
90-416 | ProSci | 100 ug | EUR 374.1 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
CD152 [CTLA-4] Recombinant Protein |
|||
90-417 | ProSci | 500 ug | EUR 588.3 |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
Anti-Hu CD152 Alexa Fluor647 |
|||
A6-785-T100 | ExBio | 100 tests | EUR 322.8 |
Anti-Hu CD152 PE-Cy7 |
|||
T7-785-T100 | ExBio | 100 tests | EUR 321.6 |
Anti-Hu CD152 PE-Cy5 |
|||
T8-785-T100 | ExBio | 100 tests | EUR 288 |
CTLA4 /CD152 (Human) ELISA Kit |
|||
K4157-100 | Biovision | each | EUR 992.4 |
CTLA4 (CD152), Fc fusion (Human) |
|||
71149-2 | BPS Bioscience | 1 mg | EUR 1200 |
Description: Human secreted CTLA4 , Fc fusion protein, also known as Cytotoxic T-lymphocyte-associated protein 4 and CD152. GenBank Accession No. NM_005214, a.a. 36-162 expressed in a HEK293 cell expression system. MW = 40.3 kDa (monomer). This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
|||
abx139387-100tests | Abbexa | 100 tests | EUR 577.2 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
|||
abx133969-100Assays | Abbexa | 100 Assays | EUR 594 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
|||
abx133969-50Assays | Abbexa | 50 Assays | EUR 477.6 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (APC) |
|||
20-abx200696 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PerCP) |
|||
20-abx200701 | Abbexa |
|
|
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (RPE) |
|||
abx413285-100tests2ml | Abbexa | 100 tests (2 ml) | EUR 710.4 |
Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (RPE) |
|||
abx413286-25tests | Abbexa | 25 tests | EUR 376.8 |
Anti-CD152/ CTLA-4 Antibody [BNI3], Unconjugated-100ug |
|||
QAB59-100ug | EnQuireBio | 100ug | EUR 240 |
Anti-CD152/ CTLA-4 Antibody [BNI3], APC-100Tests |
|||
QAB59-APC-100Tests | EnQuireBio | 100Tests | EUR 422.4 |
Anti-CD152/ CTLA-4 Antibody [BNI3], APC-25Tests |
|||
QAB59-APC-25Tests | EnQuireBio | 25Tests | EUR 188.4 |
Anti-CD152/ CTLA-4 Antibody [BNI3], PE-100Tests |
|||
QAB59-PE-100Tests | EnQuireBio | 100Tests | EUR 310.8 |
Anti-CD152/ CTLA-4 Antibody [BNI3], PE-25Tests |
|||
QAB59-PE-25Tests | EnQuireBio | 25Tests | EUR 178.8 |
iFluor® 350 Anti-human CD152 Antibody *BN13* |
|||
11520010 | AAT Bioquest | 100 tests | EUR 245 |
iFluor® 350 Anti-human CD152 Antibody *BN13* |
|||
11520011 | AAT Bioquest | 500 tests | EUR 918 |
iFluor® 405 Anti-human CD152 Antibody *BN13* |
|||
11520020 | AAT Bioquest | 100 tests | EUR 245 |
iFluor® 405 Anti-human CD152 Antibody *BN13* |
|||
11520021 | AAT Bioquest | 500 tests | EUR 918 |
iFluor® 430 Anti-human CD152 Antibody *BN13* |
|||
11520030 | AAT Bioquest | 100 tests | EUR 245 |
iFluor® 430 Anti-human CD152 Antibody *BN13* |
|||
11520031 | AAT Bioquest | 500 tests | EUR 918 |
iFluor® 450 Anti-human CD152 Antibody *BN13* |
|||
11520040 | AAT Bioquest | 100 tests | EUR 245 |